Search Results 311-320 of 24224 for B cell lymphomas
oma, Leukemia, Cutaneous t-cell lymphoma, Skin cancer, Plasma cell ... ymphoma, B-cell lymphoma, T-cell lymphoma. Show more areas of focus for Yi ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
... B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG). Researchers say that adding the ...
Allison C. Rosenthal, D.O.. Internist; Oncologist; Hematologist. Phoenix, AZ. Areas of focus: CAR-T cell therapy, B- ...
Autologous stem-cell transplantation; CAR-T cell therapy; Adolescent Young Adult (AYA) cancer care; Cutaneous lymphomas; B cell lymphoma; T cell lymphoma ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... cell lymphomas,” says Andrew L. Feldman, M.D., a Mayo Clinic pathologist and ... ALCL is a rare type of non-Hodgkin lymphoma, but one of the more common subtypes ...
A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression ...
... cell therapy, among others. In addition, each week Mayo Clinic lymphoma doctors hold a multidisciplinary meeting to discuss treatment options. These ...
Description. Lisocabtagene maraleucel injection is used to treat large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), high grade B-cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!